The Dysregulated IL-23/TH17 Axis in Endometriosis Pathophysiology
In a study published in the Journal of Immunology, Sisnett et al. explored the therapeutic potential of endometriosis with IL-23/TH17/IL-17 axis with structured into three main investigative components: human sample analysis, in vitro cell culture experiments, and an in vivo mouse model of endometriosis. The study…
Key Points Lay Summary
By Hale Goksever CelikDoes endometriosis have an adverse effect on sperm activity?
By Hale Goksever Celik
Infertility is one of the symptoms encountered in up to 40-50% of women with endometriosis. There are several pathophysiological theories suggesting the development of endometriosis-associated infertility such as altered pelvic anatomy, adhesions, disrupted ovarian reserve/function and compromised endometrial receptivity as…
Key Points Lay Summary
The association between inflammatory cytokines and fertility in women with endometriosis
By Hale Goksever Celik
Women with endometriosis suffer not only from a broad spectrum of symptoms including pain including dysmenorrhea, dyspareunia, and chronic pelvic pain but also fertility problems. Endometriosis-associated infertility develops depending on a combination of several mechanisms such as distorted pelvic anatomy,…
Key Points Lay Summary
Environmental factors play a role in the development of endometriosis
By Hale Goksever Celik
The proposed mechanisms underlying the development of endometriosis may be classified into three groups: in-situ theory, implantation theories, and induction theories. Genetic, hormonal, environmental, and lifestyle-related factors are also involved as no mechanism is solely responsible for endometriosis development. Although there are…
Key Points Lay Summary
By Dr. Youngran ParkA Possible genetic target for endometriosis treatment
By Dr. Youngran Park
Mutations in the chromosome remodeling complex SWI/SNF subunit ARID1A were first identified in ovarian clear-cell carcinoma and ovarian endometrioid carcinoma, two endometriosis-associated epithelial ovarian cancer subtypes. ARID1A gene mutations are also observed in deep ovarian and deep infiltrating endometriosis, atypical endometrial…
Key Points Lay Summary
CXCR4 or CXCR7 antagonists as novel therapies for endometriosis
By Dr. Youngran Park
Endometriosis is a common, estrogen-dependent chronic inflammatory disorder. It affects approximately 5-10% of reproductive-aged women and 20-50% of infertile women. Endometriosis also has a significant social and psychological impact on the lives of women. Despite such a significant burden, there…
Key Points Lay Summary
By Selma OransayWhat happens to women with endometriosis after menopause?
By Selma Oransay
Endometriosis affects women in their reproductive period of life, with expected regression of lesions in the postmenopausal period. Literature about postmenopausal endometriosis assessing the prevalence, pathogenesis, and treatment is limited. As 2-5 % of postmenopausal women are affected by this uncommon condition, developing stress…
Key Points Lay Summary
Seven Hormonal Biomarkers for Diagnosing Endometriosis
By Dr. Youngran Park
Endometriosis is an inflammatory condition characterized by implantation and invasive growth of endometrial tissue outside the uterine cavity. Although it is benign, endometriosis has cancer-like features, a mutation profile similar to that of ovarian cancer, and increased ovarian cancer risk.…
Key Points Lay Summary
Novel inhibitors of estrogen biosynthesis
By Dr. Youngran Park
Endometriosis is a chronic benign disease which is estrogen-dependent. Estradiol creates a positive feedback loop with the synthesis of pro-inflammatory mediators, which sustains further disease establishment and causes the pain symptoms. However, hormone therapies do not cure definitively endometriosis, because…
Key Points Lay Summary
The Wnt/b-catenin signaling in endometriosis
By Dr. Youngran Park
Endometriosis is a very common gynecological disorder, which affects approximately 10% of reproductive-aged women, and is one of the most common reasons for infertility. The normal endometrium undergoes cyclical remodeling under control of sex hormones secreted by ovaries- estrogen and…
Key Points Lay Summary
The reason for lower BMI and less body fat in women with endometriosis.
By Selma Oransay
Zolbin et al. from the Department of Obstetrics and Gynecology of Yale School of Medicine, New Haven, USA, recently published the results of their prospective controlled research on adipocyte alterations in endometriosis, in the journal "Reproductive Biology and Endocrinology". Endometriosis can…
Key Points Lay Summary
By Özge ÖzkayaNew Link Between Endometriosis and Genetics?
By Özge Özkaya
Two new genes have been identified that may be associated with endometriosis. This finding increases our understanding of the biology of endometriosis and may take us one small step further towards the development of new ways of treating the condition. …
Key Points Lay Summary
A link between endometrioid ovarian carcinoma and endometriosis.
By Selma Oransay
Ciavattini et al.from Polytechnic University Ancona, Italy create a pilot study which recently published in Oncology Letters to clarify the link between endometriosis and endometrioid ovarian cancer. The unfolded protein response (UPR) activity as a promoter of neoplastic progression of malignancies is…
Key Points Lay Summary
The role of circulating microRNA's in Endometriosis
By Dr. Youngran Park
Endometriosis is an estrogen-dependent disorder. This disease affects approximately 10% of reproductive-aged women and 20% to 50% of infertile women. Steroidogenic factor 1 (SF-1) is an essential transcriptional regulator coordinately regulating multiple genes involved in estrogen biosynthesis. SF-1 is known…
Key Points Lay Summary
IL-37 regulates ectopic endometrial stromal cells to prevent endometriosis
By Dr. Youngran Park
Endometriosis has been identified as a chronic inflammatory disease. It has been shown that in the plasma and peritoneal fluid, women with endometriosis exhibit aberrant numbers of immune cells and concentrations of cytokines and chemokines that promote a chronic inflammatory…
Key Points Lay Summary
PROPOFOL: a new combat for endometriosis?
By Selma Oransay
Feng et al, from the Department of Gynecology Weifang Medical University Hospital, Shandong, China, recently published their prospective experimental research in the journal Experimental and Therapeutic Medicine. Propofol, a rapid and short-term anesthetic substance, recently has been shown to prevent cancer through inhibiting…
Key Points Lay Summary
By Murat OsmanCoumarin based compounds found to inhibit the estradiol synthesis pathway
By Murat Osman
Endometriosis is a disease characterized by ectopic endometrial tissue outside the endometrium. Several biochemical and molecular pathways have been researched and used to alleviate endometriosis symptoms by inhibiting key molecules involved in the menstrual cycle. This review paper by Niinivehmas…
Key Points Lay Summary
By Kasthuri NairEFA Medical Conference 2017: "Ovarian Cancer" Presentation by Dr. Jeannine Villella
By Kasthuri Nair
Dr. Jeannine Villella, the Chair of Gynecologic Oncology in the Department of OBGYN at Lenox Hill, presented at the 2017 EFA Medical Conference. Her presentation was titled “Ovarian Cancer, ” and she discussed the similarities, differences, and links between ovarian…
Key Points Lay Summary
A Potential New Drug for Endometriosis?
By Özge Özkaya
A steroid derivative called PBRM could be a new emerging drug to treat endometriosis according to a study by Canadian scientists. In the study that was published in The Journal of Steroid Biochemistry and Molecular Biology, researchers characterized the pharmaceutical…
Key Points Lay Summary
EFA Medical Conference 2017: "Fertility Preservation to BRCA Mutations" Presentation by Dr. Kutluk Oktay
By Kasthuri Nair
Dr. Kutluk Oktay is the Director of the Laboratory of Molecular Reproduction & Fertility Preservation as well as a Professor of OBGYN at Yale University School of Medicine. Dr. Oktay also presented at the EFA 2017 Medical Conference, and his…
Key Points Lay Summary
EFA Medical Conference 2017: "Hormone and Cytokine Sensitivity in Endometriosis" Presentation by Dr. Robert Taylor
By Kasthuri Nair
The first presenter of the “Estrogen from Inflammation to Cancer: A Distant Link?” section of EFA 2017 Medical Conference was Dr. Robert Taylor from Wake Forest University Health Sciences. Dr. Taylor’s presentation was titled “Hormone and Cytokine Sensitivity in Endometriosis.”…
Key Points Lay Summary
EFA Medical Conference 2017: “Literature Review, Our Data, and Case Presentations” by Dr. Karli Goldstein
By Özge Özkaya
Dr. Karli Goldstein started her presentation with a brief literature review on the relationship between endometriosis and breast cancer. She focused on a research article by Dr. Spandidos and colleagues, which was the first epidemiological study that examined the possible…
Key Points Lay Summary
EFA Medical Conference 2017: "NIH Funding - Present and Future" Presentation by Dr. Lisa Halvorson
By Kasthuri Nair
Dr. Lisa Halvorson, the Chief at the Gynecologic Health and Disease Branch at the National Institute of Health (NIH)/NICHD/HHS, gave a presentation titled “NIH Funding - Present and Future” at the EFA 2107 Medical conference. Dr. Halvorson’s presentation began with…
Key Points Lay Summary
EFA Medical Conference 2017: "Breast Cancer in Young Women; Early Diagnosis Timely Intervention" Presentation by Dr. Stephanie Bernik
By Kasthuri Nair
Dr. Stephanie Bernik is the Chief of Surgical Oncology of Surgery and General Surgery at the Lenox Hill Hospital. She recently presented at the EFA 2017 Medical Conference, and her presentation was titled “Breast Cancer in Young Women; Early Diagnosis…
Key Points Lay Summary
EFA Medical Conference 2017: "Prophylactic Mastectomy and Breast Reconstruction" Presentation by Dr. Oren Lerman
By Özge Özkaya
Dr. Oren Lerman, a plastic and reconstructive surgeon at Lenox Hill Hospital in New York City, described the reconstructive options of a woman who has been or is going to go through a mastectomy (removal of breast tissues) whether it…
Key Points Lay Summary
EFA Medical Conference 2017: "Endometriosis: hormonal or surgical? My reality!" Presentation by Dr. Harry Reich
By Kasthuri Nair
Dr. Harry Reich, the Former Director of Advanced Laparoscopic Surgery at Columbia University Department of OBGYN, was the last speaker in the Mission and History part of the EFA 2017 Medical Conference. His presentation was titled “Endometriosis: hormonal or surgical?…
Key Points Lay Summary
EFA Medical Conference 2017: "Cells Are the New Cure" Presentation by Dr. Max Gomez
By Kasthuri Nair
Dr. Max Gomez is an award-winning broadcast journalist, CBS News Medical Correspondent, and a presenter at the EFA 2017 Medical Conference. Dr. Gomez’s presentation was titled “Cells Are the New Cure: The Cutting-Edge Medical Breakthroughs That Are Transforming Our Health.”…
Key Points Lay Summary
What is the role of hormones on the function and development of the brain?
By Murat Osman
Dr. Sarah L. Berga, Professor, and Chair of Obstetrics and Gynecology Wake Forest School of Medicine aim to talk about the effects of sex hormones such as estrogens and progestins on brain health with an emphasis on the neuroprotective characteristics…
Key Points Lay Summary
EFA.MC.2017.“The Abnormal Embryos That Aren’t”,“Tens of thousands of women thought they couldn't have babies: But what if they could.”Dr. Norbert Gleicher Dr. Monica Halem
By Özge Özkaya
The presentation started with the story of Monica Halem who had endometriosis and had been trying to conceive using in vitro fertilization VF), but was told that none of her fertilized embryos would be viable based on pre-implantation genetic screening…
Key Points Lay Summary
EFA Medical Conference 2017: EFA Research Grants Presentation by Dr. Serin Seckin
By Kasthuri Nair
Dr. Serin Seckin, a Resident Physician at Mount Sinai Health System, gave a presentation during the 2017 Medical Conference titled “EFA Research Grants.” This presentation delineated and went into some detail about the research grants worth over $400,000 that were…
Key Points Lay Summary
EFA Medical Conference 2017: "The Environmental Risks of Breast Cancer" Presentation by Dr. Marisa Weiss
By Kasthuri Nair
The second speaker in the subsection of the conference titled “Estrogen from Inflammation to Cancer: A Distant Link?” was Dr. Marisa Weiss and she gave a presentation titled “The Environmental Risks of Breast Cancer: Common Ground with Endometriosis.” Dr. Weiss…
Key Points Lay Summary
EFA Medical Conference 2017: Welcome Presentation by Dr. Tamer Seckin
By Kasthuri Nair
The first part of the Endometriosis Foundation of America’s 2017 Medical Conference delved into the mission and history of the Endometriosis Foundation of America. The first presenter was Dr. Tamer Seckin, a renowned surgeon, and gynecologist who is also the…
Key Points Lay Summary
CCL19/CCR7 Interaction can Casue Characteristic Cell Proliferation
By Kasthuri Nair
In their paper published in the American Journal of Reproductive Immunology titled “CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs,” Diao et al. hope to elucidate one of the mechanisms…
Key Points Lay Summary
Retinoic Acid Signaling Involved in Endometrial Decidualization
By Murat Osman
Decidualization occurs in the eutopic endometrium during the luteal phase and is controlled by signaling pathways such as cyclic adenosine monophosphate (cAMP) and progesterone. Researchers from the Northwestern University School of Medicine reported in their recent paper entitled "Altered Retinoid…
Key Points Lay Summary
Combination Therapy Proves More Efficient in the Treatment of Endometriosis
By Kasthuri Nair
In their recent paper in British Journal of Pharmacology, entitled “Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions,” Nenicu et al. illustrate the increased effectiveness of telmisartan used along with a cyclooxygenase-2 (COX-2) inhibitor (a non-steroidal anti-inflammatory…
Key Points Lay Summary